---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-034750"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2023-09-29T23:59:59+00:00"
generated_at: "2026-06-10T07:06:10.542429+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Semper Paratus regains Nasdaq MVLS compliance effective Sept 28, 2023

## Summary
- Company received Nasdaq letter Sept 28, 2023 confirming regained compliance with MVLS Rule (minimum $50M market value).
- Non-compliance notice received April 7, 2023; initial cure period ran to Oct 2, 2023.
- MVLS exceeded $50M for ten consecutive business days from Sept 14 to Sept 27, 2023.
- Compliance regained; delisting risk from Nasdaq Global Market is removed.

## SEC filing metadata
- accession: 0001493152-23-034750
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2023-09-29T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315223034750/0001493152-23-034750-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315223034750/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-034750
- JSON: https://secwatch.observer/filing/0001493152-23-034750.json
- Plain text: https://secwatch.observer/filing/0001493152-23-034750.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.